Bone Histomorphometry in Diabetes Mellitus

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2015 Aug 6

PMID 26243361

Citations 4

Authors

C A Moreira

D W Dempster

Affiliations

Soon will be listed here.

Citing Articles

Microstructural abnormalities are evident by histology but not HR-pQCT at the periosteal cortex of the human tibia under CVD and T2D conditions.

Garita B, Maligro J, Sadoughi S, Wu P, Liebenberg E, Horvai A Med Nov Technol Devices. 2023; 10.

PMID: 37383338 PMC: 10306320. DOI: 10.1016/j.medntd.2021.100062.

Hip Fracture Risk According to Diabetic Kidney Disease Phenotype in a Korean Population.

Lee S, Yoo J, Kim K, Han K, Choi H Endocrinol Metab (Seoul). 2022; 37(1):148-158.

PMID: 35255607 PMC: 8901970. DOI: 10.3803/EnM.2021.1315.

The impact of type 2 diabetes on bone metabolism.

Sanches C, Daher Vianna A, Barreto F Diabetol Metab Syndr. 2017; 9:85.

PMID: 29075333 PMC: 5649056. DOI: 10.1186/s13098-017-0278-1.

Imaging of diabetic bone.

Ponti F, Guerri S, Sassi C, Battista G, Guglielmi G, Bazzocchi A Endocrine. 2017; 58(3):426-441.

PMID: 28293856 DOI: 10.1007/s12020-017-1278-5.

References

Strotmeyer E, Cauley J, Orchard T, Steenkiste A, Dorman J . Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care. 2006; 29(2):306-11. DOI: 10.2337/diacare.29.02.06.dc05-1353. View

Farr J, Drake M, Amin S, Melton 3rd L, McCready L, Khosla S . In vivo assessment of bone quality in postmenopausal women with type 2 diabetes. J Bone Miner Res. 2013; 29(4):787-95. PMC: 3961509. DOI: 10.1002/jbmr.2106. View

Giangregorio L, Leslie W, Lix L, Johansson H, Oden A, McCloskey E . FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res. 2011; 27(2):301-8. DOI: 10.1002/jbmr.556. View

Mastrandrea L, Wactawski-Wende J, Donahue R, Hovey K, Clark A, Quattrin T . Young women with type 1 diabetes have lower bone mineral density that persists over time. Diabetes Care. 2008; 31(9):1729-35. PMC: 2518333. DOI: 10.2337/dc07-2426. View

Gaudio A, Privitera F, Battaglia K, Torrisi V, Sidoti M, Pulvirenti I . Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97(10):3744-50. DOI: 10.1210/jc.2012-1901. View

Leite Duarte M, da Silva R . [Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID)]. Rev Hosp Clin Fac Med Sao Paulo. 1996; 51(1):7-11. View

Schwartz A, Vittinghoff E, Sellmeyer D, Feingold K, de Rekeneire N, Strotmeyer E . Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2007; 31(3):391-6. PMC: 2288549. DOI: 10.2337/dc07-1152. View

Krakauer J, McKenna M, Buderer N, Rao D, WHITEHOUSE F, Parfitt A . Bone loss and bone turnover in diabetes. Diabetes. 1995; 44(7):775-82. DOI: 10.2337/diab.44.7.775. View

Garcia-Martin A, Rozas-Moreno P, Reyes-Garcia R, Morales-Santana S, Garcia-Fontana B, Garcia-Salcedo J . Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2011; 97(1):234-41. DOI: 10.1210/jc.2011-2186. View

10.

Yamamoto M, Yamaguchi T, Nawata K, Yamauchi M, Sugimoto T . Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab. 2012; 97(4):1277-84. DOI: 10.1210/jc.2011-2537. View

11.

Jackuliak P, Payer J . Osteoporosis, fractures, and diabetes. Int J Endocrinol. 2014; 2014:820615. PMC: 4094869. DOI: 10.1155/2014/820615. View

12.

Liao C, Lin C, Shih C, Yeh C, Chang Y, Lee Y . Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care. 2014; 37(8):2246-52. DOI: 10.2337/dc13-2957. View

13.

Schwartz A, Garnero P, Hillier T, Sellmeyer D, Strotmeyer E, Feingold K . Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009; 94(7):2380-6. PMC: 2708944. DOI: 10.1210/jc.2008-2498. View

14.

Saito M, Kida Y, Kato S, Marumo K . Diabetes, collagen, and bone quality. Curr Osteoporos Rep. 2014; 12(2):181-8. DOI: 10.1007/s11914-014-0202-7. View

15.

Ardawi M, Akhbar D, Alshaikh A, Ahmed M, Qari M, Rouzi A . Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone. 2013; 56(2):355-62. DOI: 10.1016/j.bone.2013.06.029. View

16.

Klein , Frost H, Sedlin E . A PILOT STUDY OF LAMELLAR BONE PHYSIOLOGY IN DIABETES MELLITUS. Henry Ford Hosp Med Bull. 1964; 12:55-62. View

17.

Manavalan J, Cremers S, Dempster D, Zhou H, Dworakowski E, Kode A . Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97(9):3240-50. PMC: 3431571. DOI: 10.1210/jc.2012-1546. View

18.

Armas L, Akhter M, Drincic A, Recker R . Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus. Bone. 2011; 50(1):91-6. PMC: 3246575. DOI: 10.1016/j.bone.2011.09.055. View

19.

Gennari L, Merlotti D, Valenti R, Ceccarelli E, Ruvio M, Pietrini M . Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012; 97(5):1737-44. DOI: 10.1210/jc.2011-2958. View

20.

Vestergaard P . Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--a meta-analysis. Osteoporos Int. 2006; 18(4):427-44. DOI: 10.1007/s00198-006-0253-4. View